ATE425989T1 - Proteinreinigungsverfahren - Google Patents

Proteinreinigungsverfahren

Info

Publication number: ATE425989T1
Authority: AT; Austria
Prior art keywords: protein; purification process; protein purification; bind; proteins
Prior art date: 2001-12-21

Application number

AT02794380T

Other languages

English (en)

Inventor

Ganesh Vedantham

Clayton Brooks

Joanne Reeder

Andrew Goetze

Original Assignee

Immunex Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-21

Filing date

2002-12-20

Publication date

2009-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27407561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE425989(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-12-20 Application filed by Immunex Corp filed Critical Immunex Corp

2009-04-15 Application granted granted Critical

2009-04-15 Publication of ATE425989T1 publication Critical patent/ATE425989T1/de

Links

238000000034 method Methods 0.000 title abstract 3
238000001742 protein purification Methods 0.000 title 1
102000004169 proteins and genes Human genes 0.000 abstract 10
108090000623 proteins and genes Proteins 0.000 abstract 10
229910052588 hydroxylapatite Inorganic materials 0.000 abstract 2
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract 2
108060003951 Immunoglobulin Proteins 0.000 abstract 1
238000001042 affinity chromatography Methods 0.000 abstract 1
238000004587 chromatography analysis Methods 0.000 abstract 1
102000018358 immunoglobulin Human genes 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Immunology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Cell Biology (AREA)
Analytical Chemistry (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT02794380T 2001-12-21 2002-12-20 Proteinreinigungsverfahren ATE425989T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US34336301P	2001-12-21	2001-12-21
US34718902P	2002-01-08	2002-01-08
US36427202P	2002-03-12	2002-03-12

Publications (1)

Publication Number	Publication Date
ATE425989T1 true ATE425989T1 (de)	2009-04-15

Family

ID=27407561

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02794380T ATE425989T1 (de)	2001-12-21	2002-12-20	Proteinreinigungsverfahren

Country Status (11)

Country	Link
US (2)	US7122641B2 (de)
EP (1)	EP1463942B2 (de)
JP (1)	JP4363986B2 (de)
AT (1)	ATE425989T1 (de)
AU (1)	AU2002359816B2 (de)
CA (1)	CA2469815C (de)
DE (1)	DE60231651D1 (de)
ES (1)	ES2322945T5 (de)
MX (1)	MXPA04006053A (de)
PL (1)	PL374311A1 (de)
WO (1)	WO2003059935A2 (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7329388B2 (en)	1999-11-08	2008-02-12	Princeton Biochemicals, Inc.	Electrophoresis apparatus having staggered passage configuration
US6406604B1 (en)	1999-11-08	2002-06-18	Norberto A. Guzman	Multi-dimensional electrophoresis apparatus
ES2322945T5 (es) *	2001-12-21	2012-10-17	Immunex Corporation	Métodos para purficación de proteína
EP3225625A1 (de) *	2002-09-11	2017-10-04	Chugai Seiyaku Kabushiki Kaisha	Proteinaufreinigungsverfahren
GB0304576D0 (en) *	2003-02-28	2003-04-02	Lonza Biologics Plc	Protein a chromatography
US7850970B2 (en) *	2003-08-26	2010-12-14	The Regents Of The University Of Colorado	Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
KR101221862B1 (ko) *	2003-10-27	2013-01-14	와이어쓰 엘엘씨	하이드록시아파타이트 크로마토그래피를 사용한 고분자량응집체의 제거
JP2007510935A (ja)	2003-11-07	2007-04-26	プリンストン・バイオケミカルズ・インコーポレーテッド	多次元電気泳動装置
US8007724B2 (en)	2003-11-07	2011-08-30	Princeton Biochemicals, Inc.	Electrophoresis apparatus having at least one auxiliary buffer passage
WO2005071410A1 (en) *	2004-01-13	2005-08-04	Tanox, Inc.	Detecting and quantifying host cell proteins in recombinant protein products
JP4872327B2 (ja) *	2004-11-26	2012-02-08	東レ株式会社	改質されたインターロイキン−１１とその製造方法
EP1869065B1 (de) *	2005-03-11	2020-05-06	Wyeth LLC	Verfahren zur chromatographie mit schwacher partition
US20060240564A1 (en) *	2005-04-20	2006-10-26	Chia-Hui Shieh	pH gradient ion exchange LC-MS and mass compatible buffers
BRPI0611901A2 (pt)	2005-06-14	2012-08-28	Amgen, Inc	composição, liofilizado, kit, e, processo para preparar uma composição
US7375188B2 (en) *	2005-07-29	2008-05-20	Mallinckrodt Baker, Inc.	Vegetarian protein a preparation and methods thereof
MY185597A (en) *	2005-09-20	2021-05-24	Avantor Performance Mat Inc	Vegetarian protein a preparation and methods thereof
EP1816201A1 (de)	2006-02-06	2007-08-08	CSL Behring GmbH	Modifizierter Koagulationsfaktor VIIa mit verbesserter 'half-life'-Stabiltät
CN102887955A (zh)	2006-04-05	2013-01-23	艾博特生物技术有限公司	抗体纯化
EP1867660A1 (de)	2006-06-14	2007-12-19	CSL Behring GmbH	Fusionsprotein welches proteolytisch geschnitten werden kann und einen Faktor der Blutgerinnungskaskade enthält
EP2032607B2 (de)	2006-06-14	2017-02-22	CSL Behring GmbH	Proteolytisch spaltbares fusionsprotein, das einen blutgerinnungsfaktor enthält
JP2010510963A (ja) *	2006-06-14	2010-04-08	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー	セラミックヒドロキシアパタイトを使用する抗体の精製方法
US7939632B2 (en)	2006-06-14	2011-05-10	Csl Behring Gmbh	Proteolytically cleavable fusion proteins with high molar specific activity
SI2061803T2 (sl)	2006-08-28	2023-01-31	Ares Trading S.A.	Postopek za čiščenje proteinov, ki vsebujejo FC
WO2008025747A1 (en) *	2006-08-28	2008-03-06	Ares Trading S.A.	Process for the purification of fc-fusion proteins
JP2010501622A (ja) *	2006-08-28	2010-01-21	アレストレーディングソシエテアノニム	Ｆｃ−融合タンパク質の精製法
US8911964B2 (en)	2006-09-13	2014-12-16	Abbvie Inc.	Fed-batch method of making human anti-TNF-alpha antibody
AU2007294731B2 (en)	2006-09-13	2014-04-17	Abbvie Inc.	Cell culture improvements
US7488807B2 (en) *	2006-11-22	2009-02-10	3M Innovative Properties Company	Antibody with protein A selectivity
US20100047252A1 (en) *	2006-11-22	2010-02-25	3M Innovative Properties Company	Antibody with protein a selectivity
CA2673459C (en)	2006-12-22	2016-09-13	Stefan Schulte	Modified coagulation factors with prolonged in vivo half-life
EP2238154B1 (de) *	2008-01-18	2015-09-16	Bio-Rad Laboratories, Inc.	Erweiterte reinigung phosphorylierter und nicht phosphorylierter biomoleküle durch apatit-chromatographie
US20100058173A1 (en) *	2008-08-28	2010-03-04	Kabushiki Kaisha Toshiba	Display processing apparatus, display processing method, and computer program product
CN102164954B (zh) *	2008-09-23	2018-04-06	弗·哈夫曼-拉罗切有限公司	促红细胞生成素的纯化
NZ592095A (en)	2008-10-20	2013-01-25	Abbott Lab	Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
BRPI0920572A8 (pt)	2008-10-20	2015-10-27	Abbott Lab	Inativação viral durante a purificação dos anticorpos
US8058407B2 (en)	2008-10-31	2011-11-15	Wyeth Llc	Purification of acidic proteins using ceramic hydroxyapatite chromatography
US8945895B2 (en)	2009-07-31	2015-02-03	Baxter International Inc.	Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
JP2013512674A (ja) *	2009-12-02	2013-04-18	アクセルロンファーマ，インコーポレイテッド	Ｆｃ融合タンパク質の血清半減期を増加させるための組成物および方法
WO2011088225A1 (en)	2010-01-15	2011-07-21	Bio-Rad Laboratories, Inc.	Surface neutralization of apatite
SG10201503899SA (en) *	2010-05-18	2015-06-29	Abbvie Inc	Apparatus And Process Of Purification Of Proteins
US8895707B2 (en)	2010-08-18	2014-11-25	Bio-Rad Laboratories, Inc.	Elution of proteins from hydroxyapatite resins without resin deterioration
EP2670704B1 (de) *	2011-02-02	2018-12-12	Bio-Rad Laboratories, Inc.	Apatitoberflächenneutralisierung mit alkalischen lösungen
US9062106B2 (en)	2011-04-27	2015-06-23	Abbvie Inc.	Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US8911992B2 (en) *	2011-04-28	2014-12-16	Bio-Rad Laboratories, Inc.	DNA removal in target molecule purification
EP2718328A4 (de)	2011-06-08	2014-12-24	Acceleron Pharma Inc	Zusammensetzungen und verfahren zur erhöhung der halbwertszeit von serum
WO2012178102A2 (en)	2011-06-24	2012-12-27	The Regents Of The Unversity Of Colorado, A Body Corporate	Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
DK2729482T3 (en)	2011-07-08	2018-05-07	Merck Sharp & Dohme	PROCEDURE FOR CLEANING FC-FUSION PROTEIN
CA2896951A1 (en)	2012-01-10	2013-07-18	The Regents Of The University Of Colorado, A Body Corporate	Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
WO2013158273A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en)	2013-03-14	2015-06-30	Abbvie, Inc.	Protein purification using displacement chromatography
WO2013158279A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Protein purification methods to reduce acidic species
WO2013176754A1 (en)	2012-05-24	2013-11-28	Abbvie Inc.	Novel purification of antibodies using hydrophobic interaction chromatography
US9815695B2 (en)	2012-05-30	2017-11-14	Bio-Rad Laboratories, Inc.	In situ restoration of apatite-based chromatography resins
HK1211981A1 (en)	2012-09-02	2016-06-03	Abbvie Inc.	Methods to control protein heterogeneity
US9512214B2 (en)	2012-09-02	2016-12-06	Abbvie, Inc.	Methods to control protein heterogeneity
CN104812901B (zh)	2012-09-13	2018-08-10	美国印第安纳大学研究和技术公司	赋予植物抗病性的组合物和系统及其使用方法
HK1207960A1 (en)	2013-03-12	2016-02-19	Abbvie Inc.	Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en)	2013-03-13	2018-07-17	Amgen Inc.	Protein purification methods to remove impurities
WO2014159579A1 (en)	2013-03-14	2014-10-02	Abbvie Inc.	MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en)	2013-10-18	2015-04-28	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en)	2013-03-14	2016-11-22	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
SI3395423T1 (sl)	2013-03-14	2023-12-29	Amgen Inc.	Odstranjevanje izluženega liganda za afinitetno čiščenje
US9598667B2 (en)	2013-10-04	2017-03-21	Abbvie Inc.	Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en)	2013-10-18	2015-11-10	Abbvie, Inc.	Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en)	2013-10-18	2015-07-21	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same
US8946395B1 (en)	2013-10-18	2015-02-03	Abbvie Inc.	Purification of proteins using hydrophobic interaction chromatography
US20150139988A1 (en)	2013-11-15	2015-05-21	Abbvie, Inc.	Glycoengineered binding protein compositions
US9802822B2 (en)	2014-06-23	2017-10-31	Bio-Rad Laboratories, Inc.	Apatite pretreatment
CN105407917B (zh) *	2014-06-23	2021-07-06	生物辐射实验室股份有限公司	磷灰石原位恢复
GB2528301A (en) *	2014-07-17	2016-01-20	Univ Newcastle	Biomolecule separation using apatite
US10814305B2 (en) *	2016-09-29	2020-10-27	Bio-Rad Laboratories, Inc.	Agarose-filled ceramic apatite
PT3528787T (pt)	2016-10-21	2026-03-11	Amgen Inc	Formulações farmacêuticas e métodos para produzir as mesmas
US12516102B1 (en) *	2017-02-09	2026-01-06	Bracco Suisse Sa	Process for the purification of soluble PSGL-1 protein variants
CN112996801A (zh) *	2018-11-26	2021-06-18	北卡罗来纳州大学	用于捕获宿主细胞蛋白的肽配体
EP4106897A4 (de)	2020-02-19	2023-10-25	Bio-Rad Laboratories, Inc.	Verfahren zur herstellung von polymergefülltem chromatografieharz
AU2021262609A1 (en) *	2020-05-01	2022-12-22	Kashiv Biosciences, Llc	An improved process of purification of protein
KR20230124578A (ko)	2020-12-22	2023-08-25	암젠 인크	세포 배양 방법
WO2025038763A1 (en) *	2023-08-15	2025-02-20	Bristol-Myers Squibb Company	Ceramic hydroxyapatite chromatography flow through method

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4745183A (en) *	1984-02-21	1988-05-17	Bio-Rad Laboratories, Inc.	Use of hydroxylapatite for the analysis and preparation of purified monoclonal antibodies
DE3738541A1 (de) *	1987-11-13	1989-05-24	Hoechst Ag	Verfahren zur isolierung und reinigung von hirudin
JPH0774231B2 (ja)	1986-12-11	1995-08-09	東燃株式会社	抗体の分離方法
US4933286A (en) *	1987-03-30	1990-06-12	Plant Cell Research Institute, Inc.	Purification of apase-11 and retrieval of the nematode resistance gene
US5115101A (en) *	1988-06-08	1992-05-19	Miles Inc.	Removal of protein A from antibody preparations
JPH022937A (ja)	1988-06-17	1990-01-08	Toray Ind Inc	酵素標識抗体の分離精製方法
JPH03139292A (ja)	1989-05-22	1991-06-13	Toray Ind Inc	ヒトインタ―ロイキン―６に対するモノクロ―ナル抗体
US5395760A (en) *	1989-09-05	1995-03-07	Immunex Corporation	DNA encoding tumor necrosis factor-α and -β receptors
EP0939121B2 (de) *	1989-09-12	2007-12-26	AHP Manufacturing B.V.	TFN-bindende Proteine
JPH03291300A (ja)	1989-12-28	1991-12-20	Mitsui Toatsu Chem Inc	ポリクローナル抗体の分離方法
GB9007657D0 (en) *	1990-04-04	1990-05-30	Connaught Lab	Purification of a pertussis outer membrane protein(omp69)
JPH04368399A (ja)	1991-06-12	1992-12-21	Toagosei Chem Ind Co Ltd	抗体の分離方法
JP2961986B2 (ja)	1991-08-22	1999-10-12	東亞合成株式会社	ポリクローナル抗体の分離精製方法
DE4205938A1 (de) *	1992-02-27	1993-09-02	Medac Klinische Spezialpraep	Immunotoxine
JP3178080B2 (ja)	1992-04-28	2001-06-18	チッソ株式会社	抗体の分離精製方法
US5278284A (en) *	1992-05-14	1994-01-11	Miller Brewing Company	Protein purification method
US6099830A (en) *	1994-08-09	2000-08-08	Zymogenetics, Inc.	Methods for stimulating erythropoiesis using hematopoietic proteins
US5641655A (en) *	1994-11-30	1997-06-24	Zymogenetics, Inc.	Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
JPH08188599A (ja)	1995-01-09	1996-07-23	Toagosei Co Ltd	ＩｇＹ抗体の分離精製方法
US5744587A (en) *	1995-06-07	1998-04-28	Zymogenetics, Inc.	Method for purifying thrombopoietin
DE69738075T2 (de) *	1996-11-27	2008-05-21	Genentech, Inc., South San Francisco	Affinitätsreinigung von polypeptiden an einer protein a-matrix
CA2289665C (en) *	1997-06-13	2005-08-09	Genentech, Inc.	Protein recovery by chromatography followed by filtration upon a charged layer
ES2322945T5 (es) *	2001-12-21	2012-10-17	Immunex Corporation	Métodos para purficación de proteína
WO2003059936A2 (en) *	2002-01-10	2003-07-24	Syngenta Participations Ag	Phytophthora Infestans CDC 14 Phosphatase Gene, Protein and Methods of Use

2002
- 2002-12-20 ES ES02794380T patent/ES2322945T5/es not_active Expired - Lifetime
- 2002-12-20 US US10/327,495 patent/US7122641B2/en not_active Expired - Lifetime
- 2002-12-20 DE DE60231651T patent/DE60231651D1/de not_active Expired - Lifetime
- 2002-12-20 AU AU2002359816A patent/AU2002359816B2/en not_active Expired
- 2002-12-20 EP EP02794380A patent/EP1463942B2/de not_active Expired - Lifetime
- 2002-12-20 CA CA2469815A patent/CA2469815C/en not_active Expired - Fee Related
- 2002-12-20 MX MXPA04006053A patent/MXPA04006053A/es active IP Right Grant
- 2002-12-20 PL PL02374311A patent/PL374311A1/xx not_active Application Discontinuation
- 2002-12-20 AT AT02794380T patent/ATE425989T1/de not_active IP Right Cessation
- 2002-12-20 JP JP2003560037A patent/JP4363986B2/ja not_active Expired - Lifetime
- 2002-12-20 WO PCT/US2002/041159 patent/WO2003059935A2/en not_active Ceased
2006
- 2006-09-13 US US11/520,921 patent/US7476722B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1463942A4 (de)	2005-01-19
EP1463942B2 (de)	2012-06-20
US20030166869A1 (en)	2003-09-04
ES2322945T5 (es)	2012-10-17
AU2002359816B2 (en)	2006-07-13
AU2002359816A1 (en)	2003-07-30
PL374311A1 (en)	2005-10-03
WO2003059935A2 (en)	2003-07-24
WO2003059935A3 (en)	2003-10-16
US7122641B2 (en)	2006-10-17
CA2469815C (en)	2011-05-03
US20070010661A1 (en)	2007-01-11
DE60231651D1 (de)	2009-04-30
JP2005538686A (ja)	2005-12-22
ES2322945T3 (es)	2009-07-02
JP4363986B2 (ja)	2009-11-11
CA2469815A1 (en)	2003-07-24
MXPA04006053A (es)	2005-03-31
US7476722B2 (en)	2009-01-13
EP1463942A2 (de)	2004-10-06
EP1463942B1 (de)	2009-03-18

Legal Events

Date	Code	Title	Description
2009-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE425989T1 (de)	2009-04-15	Proteinreinigungsverfahren
ATE363491T1 (de)	2007-06-15	Reinigung von antikörpern durch protein a und ionenaustauschromatographie
DK0746398T3 (da)	2002-09-16	Antistofrensning
KR950700779A (ko)	1995-02-20	단백질의 정제방법(Protein purification)
ATE278785T1 (de)	2004-10-15	Neues verfahren zur gewinnung und reinigung von fusionsproteinen
PT1308455E (pt)	2006-08-31	Composicao compreendendo anticorpos anti-her2
DK0458841T3 (da)	1995-11-20	Fremgangsmåde til anvendelse og fremstilling af peptider
WO2002083710A3 (en)	2003-05-01	Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
DE59814468D1 (de)	2010-10-07	Verwendung monolithischer sorbentien für präparative chromatographische trennverfahren
ATE361930T1 (de)	2007-06-15	Proteinreinigung mittels chromatographie und darauffolgende filtration auf beladener schicht
ES8506902A1 (es)	1985-08-01	Un procedimiento para la purificacion de un antigeno.
DE69028513D1 (de)	1996-10-17	Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür
ATE419361T1 (de)	2009-01-15	Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus
DK1115745T3 (da)	2006-10-02	Oprensning af fibrinogen fra væsker ved udfældning og hydrofob interaktionskromatografi
DE50011030D1 (de)	2005-09-29	Verfahren zur chromatographischen fraktionierung von plasma oder serum, so erhaltene präparate und deren verwendung
ATE250966T1 (de)	2003-10-15	Adsoptionschromatographie
DE59508137D1 (de)	2000-05-11	Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
MXPA05011577A (es)	2005-12-15	Purificacion de afinidad a ciclodextrina.
WO1991015582A3 (en)	1991-12-12	Purified rap gaps, rap gap sequences, and uses thereof
ATE193021T1 (de)	2000-06-15	Lipoprotein (a)-peptide und deren verwendung
BRPI0504527A (pt)	2007-03-27	processo de purificação de proteìnas antigênicas isoladas de taenia crassiceps, kit para o diagnóstico de cisticercose e método de diagnóstico da cisticercose em animais mamìferos